TARGETED EXACT SEQUENCING INNOVATIVE SCIENCE Trademark

Trademark Overview

On Wednesday, August 11, 2021, a trademark application was filed for TARGETED EXACT SEQUENCING INNOVATIVE SCIENCE with the United States Patent and Trademark Office. The USPTO has given the TARGETED EXACT SEQUENCING INNOVATIVE SCIENCE trademark a serial number of 90877419. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, July 21, 2023. This trademark is owned by TESIS LABS LLC. The TARGETED EXACT SEQUENCING INNOVATIVE SCIENCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical lab services, namely medical and scientific laboratory services
targeted exact sequencing innovative science

General Information

Serial Number90877419
Word MarkTARGETED EXACT SEQUENCING INNOVATIVE SCIENCE
Filing DateWednesday, August 11, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, July 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements

Disclaimer with Predetermined Text"TARGETED EXACT SEQUENCING" AND "SCIENCE"
Goods and ServicesClinical lab services, namely medical and scientific laboratory services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateFriday, July 21, 2023
Primary Code042
First Use Anywhere DateWednesday, November 10, 2021
First Use In Commerce DateWednesday, November 10, 2021

Trademark Owner History

Party NameTESIS BIOSCIENCES LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPHOENIX, AZ 85016
Party NameTESIS BIOSCIENCES LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressPHOENIX, AZ 85016
Party NameTESIS LABS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLafayette, CO 80026

Trademark Events

Event DateEvent Description
Friday, July 21, 2023ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, July 21, 2023ABANDONMENT - AFTER PUBLICATION
Tuesday, July 18, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, July 6, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NON-FINAL ACTION WRITTEN
Monday, March 27, 2023ASSIGNED TO EXAMINER
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 17, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, May 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NON-FINAL ACTION E-MAILED
Monday, May 16, 2022NON-FINAL ACTION WRITTEN
Monday, May 16, 2022USE AMENDMENT ACCEPTED
Wednesday, May 11, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021AMENDMENT TO USE PROCESSING COMPLETE
Thursday, November 11, 2021USE AMENDMENT FILED
Wednesday, November 10, 2021TEAS AMENDMENT OF USE RECEIVED
Saturday, October 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 14, 2021NEW APPLICATION ENTERED

Related Keywords

science innovative sequencing exact targeted services laboratory scientific namely clinical medical